Skip to main content

Neurocognitive

Plasma Proteomic Determinants of Small Vessel Disease of the Brain: the Multi-Ethnic Study of Atherosclerosis

Authors
Rizwan Kalani, Alison E. Fohner, Thomas R. Austin, Sheina Emrani, Paul N. Jensen, Timothy Hughes, Alexis C. Wood, Alain Bertoni, Sanjiv Shah, Mohamad Habes, Tanweer Rashid, Sokratis Charisis, Keenan Walker, W.T. Longstreth, Jr, David L. Tirschwell, Bruce M. Psaty, James S. Floyd, Usman A. Tahir, Robert E. Gerszten, Jerome I. Rotter, Stephen S. Rich, Susan R. Heckbert
Name and Date of Professional Meeting
Alzheimer's Association International Conference (July 28-Aug 1, 2024)
Associated paper proposal(s)
Working Group(s)
Abstract Text
Background: The identification of novel blood-based biomarkers of small vessel disease of the brain (SVD) may improve pathophysiologic understanding and inform the development of new therapeutic strategies for prevention. We evaluated plasma proteomic associations of white matter fractional anisotropy (WMFA), white matter hyperintensity (WMH) volume, enlarged perivascular space (ePVS) volume, and the presence of microbleeds (MB) on brain magnetic resonance imaging (MRI) in the population-based Multi-Ethnic Study of Atherosclerosis (MESA).

Methods: Eligible MESA participants underwent measurement of 2941 plasma proteins with the antibody-based Olink proteomics platform from blood samples collected in 2016-2018 and completed brain MRI scans in 2018-2019. Participants with quality control exclusion of protein measurements, missing covariate data, and poor quality or missing MRI outcome variables were excluded. The cross-sectional association between the abundance of each plasma protein (normalized protein expression – a relative protein quantification unit measured on a log2 scale) was modeled separately with WMFA, WMH volume, total ePVS volume, and the presence of MBs using multivariable linear or modified Poisson regression, adjusting for demographic variables, estimated glomerular filtration rate (eGFR), and SVD risk factors. For proteins independently associated with the SVD markers on MRI, penalized regression with least absolute shrinkage and selection operator (LASSO) was used to create a parsimonious proteomic model. The Benjamini-Hochberg procedure was used to control the false discovery rate <0.05 to account for multiple hypothesis testing.

Results: Eligible participants (total N=709) had a mean age of 73 years, 53% were women, 25% were Black, 17% were Chinese, 19% were Hispanic or Latino, and 39% were White (Table 1). After adjustment for demographics, eGFR, and SVD risk factors, 769 plasma proteins were associated with WMFA (Figure). LASSO regression identified a 37-protein model predictive of WMFA (Table 2). We did not find plasma proteins to be independently associated with WMH volume, ePVS volume, or the presence of MBs.

Conclusion: Multiple circulating proteins – implicated in central nervous system myelination, lipid metabolism, angiogenesis, coagulation, cellular adhesion and migration, appetite regulation, energy homeostasis, systemic inflammation, and immune regulation – were independently associated with WMFA in a multi-ethnic cohort of older adults.
Back to top